Published July 6, 2018 | Version Accepted Version + Supplemental Material
Journal Article Open

Wolff/Cope Approach to the AB Ring of the Sesterterpenoid Variecolin

  • 1. ROR icon Bucknell University
  • 2. ROR icon Cipla (United States)
  • 3. ROR icon Lundbeck (Denmark)
  • 4. ROR icon California Institute of Technology

Abstract

A stereoselective synthesis of the AB ring of the complex sesterterpenoid variecolin is presented. Our strategy features the development of a tandem Wolff/Cope rearrangement of α-diazo cyclobutyl ketones for the construction of fused, 8-membered carbocycles. Preliminary studies revealed a facile Wolff rearrangement but a difficult vinyl ketene cyclobutane Cope rearrangement. We have leveraged an efficient microwave-promoted tandem rearrangement to prepare the desired functionalized cyclooctadienones that we envision as potential key intermediates in the convergent synthesis of variecolin.

Additional Information

© 2018 American Chemical Society. Received: November 22, 2017; Published: January 4, 2018. Special Issue: Synthesis of Antibiotics and Related Molecules. The authors thank the NIH-NIGMS (R01GM080269), Eli Lilly (predoctoral fellowship to M.R.K.), the Danish Council for Independent Research/Natural Sciences (postdoctoral fellowship to T.J.), Amgen, AbbVie, Bristol-Myers Squibb, Boehringer-Ingelheim, Merck, and Caltech for generous financial support. Dr. Takeharu Toyoshima and Angela Guerrero are acknowledged for contributions to substrate preparation and reaction scouting. Drs. David VanderVelde and Scott Ross of the Caltech NMR facility are thanked for invaluable assistance with NMR experiments and helpful discussions. Lawrence Henling and Michael Day are gratefully acknowledged for X-ray crystallographic structural determination. Dr. Mona Shahgholi and Naseem Torian are acknowledged for assistance with high-resolution mass spectrometry. The authors declare no competing financial interest.

Attached Files

Accepted Version - nihms945199.pdf

Supplemental Material - jo7b02972_si_001.pdf

Supplemental Material - jo7b02972_si_002.cif

Files

jo7b02972_si_001.pdf

Files (14.7 MB)

Name Size
md5:8f4c174aaae4225f9f98b58812285394
13.2 MB Preview Download
md5:4903d2d24f5f839b76b504c8211d6604
12.9 kB Download
md5:205071a2ccd24620dc5a05a1ed2f5741
1.4 MB Preview Download

Additional details

Identifiers

PMCID
PMC6035096
Eprint ID
84082
Resolver ID
CaltechAUTHORS:20180104-140230299

Funding

NIH
R01GM080269
Eli Lilly
Danish Council for Independent Research-Natural Sciences
Amgen
AbbVie
Bristol-Myers Squibb
Boehringer-Ingelheim
Merck
Caltech

Dates

Created
2018-01-04
Created from EPrint's datestamp field
Updated
2022-03-18
Created from EPrint's last_modified field